CLINICAL_TRIALS
trial_result
· 2017-05-18
Clinical Trial Update: A Study of Sublingual Immunotherapy in Peanut-allergic Children [Phase 2]
Summary
Phase 2 trial results update evaluating peanut sublingual immunotherapy in peanut-allergic children with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of North Carolina, Chapel Hill | Conditions: Food Hypersensitivity | Phase 2 | Status: COMPLETED | Results posted: 2017-05-18